Shanghai United Imaging Healthcare Co., Ltd. (688271)

Basic

  • Market Cap

    CN¥117.85B

  • EV

    CN¥105.99B

  • Shares Out

    824.16M

  • Revenue

    CN¥10.81B

  • Employees

    7,302

Margins

  • Gross

    49.27%

  • EBITDA

    16.39%

  • Operating

    13.83%

  • Pre-Tax

    19.18%

  • Net

    16.85%

  • FCF

    -0.99%

Returns (5Yr Avg)

  • ROA

    4.96%

  • ROE

    18.61%

  • ROCE

    14.24%

  • ROIC

    10.79%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    CN¥138.9

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    CN¥13.15

  • Earnings (Dil)

    CN¥2.21

  • FCF

    -CN¥0.13

  • Book Value

    CN¥21.83

Growth (CAGR)

  • Rev 3Yr

    45.82%

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    25.15%

  • EBITDA Fwd 2Yr

    11.99%

  • EPS Fwd 2Yr

    30.16%

  • EPS LT Growth Est

    22.51%

Dividends

  • Yield

    —

  • Payout

    9.08%

  • DPS

    CN¥0.2

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    31.22%

Select a metric from the list below to chart it

Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM
Metric
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Revenues

1,984.1

2,934.5

5,696.2

7,147.4

9,024.0

10,597.9

Other Revenues, Total

50.6

44.9

64.8

106.4

214.1

214.1

Total Revenues

2,034.7

2,979.4

5,761.0

7,253.8

9,238.1

10,812.0

Total Revenues % Chg.

—

46.4%

93.4%

25.9%

27.4%

28.0%

Cost of Goods Sold, Total

1,240.0

1,767.0

2,949.6

3,692.6

4,844.5

5,484.5

Gross Profit

794.7

1,212.5

2,811.4

3,561.2

4,393.6

5,327.5

Selling General & Admin Expenses, Total

652.3

916.3

1,166.5

1,349.9

1,760.6

2,248.3

Provision for Bad Debts

—

30.5

5.9

16.8

52.6

-10.8

R&D Expenses

548.1

575.8

752.4

967.0

1,304.0

1,805.6

Other Operating Expenses

-96.4

-130.3

-128.0

-164.5

-218.5

-211.0

Other Operating Expenses, Total

1,104.0

1,392.3

1,796.9

2,169.2

2,898.7

3,832.1

Operating Income

-309.3

-179.8

1,014.5

1,392.0

1,494.9

1,495.4

Interest Expense, Total

-42.5

-63.6

-49.0

-3.3

-0.9

-1.5

Interest And Investment Income

119.3

46.4

51.9

90.4

108.1

276.3

Net Interest Expenses

76.8

-17.2

2.9

87.1

107.2

274.8

Currency Exchange Gains (Loss)

-2.9

1.0

2.7

4.8

15.5

15.5

Other Non Operating Income (Expenses)

-0.1

-3.9

-43.9

-7.7

-53.1

-78.6

EBT, Excl. Unusual Items

-235.6

-199.9

976.3

1,476.2

1,564.4

1,707.1

Gain (Loss) On Sale Of Investments

0.0

0.8

4.9

-10.6

28.5

24.3

Gain (Loss) On Sale Of Assets

0.1

27.5

0.1

-0.2

-0.0

0.0

Asset Writedown

-49.1

-0.4

-1.8

-1.7

-0.4

12.2

Other Unusual Items

105.2

150.1

175.5

233.8

327.3

329.9

EBT, Incl. Unusual Items

-179.4

-21.8

1,155.0

1,697.5

1,919.8

2,073.5

Income Tax Expense

-47.3

26.3

218.4

294.0

269.7

237.3

Earnings From Continuing Operations

-132.1

-48.0

936.6

1,403.5

1,650.1

1,836.2

Minority Interest

6.3

-25.5

-33.7

13.7

6.0

-14.7

Net Income

-125.7

-73.5

902.9

1,417.2

1,656.1

1,821.6

Net Income to Common Incl Extra Items

-125.7

-73.5

902.9

1,417.2

1,656.1

1,821.6

Net Income to Common Excl. Extra Items

-125.7

-73.5

902.9

1,417.2

1,656.1

1,821.6

Total Shares Outstanding

—

—

724.2

724.2

824.2

824.2

Weighted Avg. Shares Outstanding

—

—

695.3

723.1

756.2

822.4

Weighted Avg. Shares Outstanding Dil

—

—

695.3

723.1

756.2

822.4

EPS

—

—

1.3

2.0

2.2

2.2

EPS Diluted

—

—

1.3

2.0

2.2

2.2

EBITDA

-204.7

-42.8

1,203.5

1,628.6

1,754.5

1,772.3